AI Portfolio Summary
In 2025 Q4, SILVERARC CAPITAL MANAGEMENT, LLC maintained a portfolio of 103 distinct positions. The most significant new addition to the portfolio was IMMUNOME INC, which now represents 3.36% of the total fund value. They heavily accumulated shares in COGENT BIOSCIENCES I, increasing their position by 52.8%. Conversely, SILVERARC CAPITAL MANAGEMENT, LLC completely exited their position in AVIDITY BIOSCIENCES .
Total Positions
103
Quarter
2025 Q4
Top Holding
ABVX (7.9%)
Top 10 Concentration
49.7%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-25 of 103
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ABVX
ABIVAX SA
|
Healthcare | 7.91% | 6.18% |
#1
Prev: #1
|
3.2 | -117,511 | -21.8% |
P
S
|
422,193 | $56,934,837 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 6.14% | 1.58% |
#2
17
Prev: #19
|
4.6 | 430,179 | 52.8% |
P
S
|
1,245,254 | $44,231,422 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
URGN
UROGEN PHARMA L...
|
Healthcare | 5.66% | 4.24% |
#3
2
Prev: #5
|
4.3 | 161,538 | 10.2% |
P
S
|
1,738,821 | $40,723,188 | 2023 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KALV
KALVISTA PHARMA...
|
Healthcare | 5.44% | 2.24% |
#4
11
Prev: #15
|
4.4 | 1,063,740 | 78.0% |
P
S
|
2,427,118 | $39,197,956 | 2021 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CELC
CELCUITY INC
|
Healthcare | 5.20% | 0.59% |
#5
39
Prev: #44
|
4.4 | 286,446 | 323.0% |
P
S
|
375,132 | $37,415,666 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NUVL
NUVALENT INC
|
Healthcare | 4.35% | 4.34% |
#6
2
Prev: #4
|
1.8 | -60,870 | -16.3% |
P
S
|
311,430 | $31,326,744 | 2022 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 4.29% | 3.58% |
#7
1
Prev: #8
|
3.8 | 75,170 | 11.1% |
P
S
|
750,136 | $30,913,105 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KOD
KODIAK SCIENCES...
|
Healthcare | 3.97% | 2.21% |
#8
8
Prev: #16
|
3.6 | 23,122 | 2.3% |
P
S
|
1,023,122 | $28,606,491 | 2023 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 3.38% | 0.37% |
#9
49
Prev: #58
|
3.5 | 31,255 | 61.0% |
P
S
|
82,465 | $24,305,734 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IMNM
IMMUNOME INC
|
Healthcare | 3.36% | — |
#10
Prev: #—
|
3.3 | 1,126,210 | no change |
NEW
|
1,126,210 | $24,190,991 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GUTS
FRACTYL HEALTH ...
|
Healthcare | 3.01% | 2.27% |
#11
3
Prev: #14
|
1.2 | -759,959 | -7.2% |
P
S
|
9,840,041 | $21,648,090 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
N/A
CALL
UNIQURE NV
|
—
|
CALL Option | 2.40% | — |
#12
Prev: #—
|
3.0 | 720,800 | no change |
NEW
|
720,800 | $17,248,744 | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
GLUE
MONTE ROSA THER...
|
Healthcare | 2.24% | 0.69% |
#13
28
Prev: #41
|
3.0 | 334,124 | 48.1% |
P
S
|
1,029,066 | $16,135,755 | 2023 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VCYT
VERACYTE INC
|
Healthcare | 2.09% | 1.09% |
#14
17
Prev: #31
|
3.0 | 121,767 | 51.6% |
P
S
|
357,558 | $15,053,192 | 2021 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CGON
CG ONCOLOGY INC
|
Healthcare | 2.08% | 3.47% |
#15
5
Prev: #10
|
1.0 | -277,188 | -43.4% |
P
S
|
361,158 | $14,995,280 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RYTM
RHYTHM PHARMACE...
|
Healthcare | 2.02% | 5.04% |
#16
14
Prev: #2
|
1.0 | -234,046 | -63.3% |
P
S
|
135,950 | $14,552,088 | 2023 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SNDX
SYNDAX PHARMACE...
|
Healthcare | 1.88% | 0.96% |
#17
15
Prev: #32
|
2.9 | 179,191 | 38.6% |
P
S
|
642,899 | $13,507,308 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BIIB
BIOGEN INC
|
Healthcare | 1.84% | 1.52% |
#18
4
Prev: #22
|
0.8 | -5,007 | -6.2% |
P
S
|
75,412 | $13,271,758 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
INSM
INSMED INC
|
Healthcare | 1.72% | 4.01% |
#19
12
Prev: #7
|
0.9 | -135,392 | -65.5% |
P
S
|
71,256 | $12,401,394 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CNTA
CENTESSA PHARMA...
|
Healthcare | 1.59% | 0.46% |
#20
32
Prev: #52
|
2.9 | 316,965 | 224.4% |
P
S
|
458,203 | $11,459,657 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VRDN
VIRIDIAN THERAP...
|
Healthcare | 1.51% | 0.76% |
#21
13
Prev: #34
|
2.7 | 89,060 | 34.3% |
P
S
|
348,569 | $10,847,467 | 2021 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ASND
ASCENDIS PHARMA...
|
Healthcare | 1.46% | 1.44% |
#22
1
Prev: #23
|
0.6 | -4,326 | -8.1% |
P
S
|
49,228 | $10,497,379 | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
PFE
PFIZER INC
|
Healthcare | 1.45% | — |
#23
Prev: #—
|
2.6 | 419,134 | no change |
NEW
|
419,134 | $10,436,437 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BNTC
BENITEC BIOPHAR...
|
Healthcare | 1.37% | 0.52% |
#24
26
Prev: #50
|
2.8 | 455,450 | 164.9% |
P
S
|
731,717 | $9,856,228 | 2021 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AVTX
AVALO THERAPEUT...
|
Healthcare | 1.32% | 1.24% |
#25
2
Prev: #27
|
0.6 | -196,486 | -27.3% |
P
S
|
524,436 | $9,523,758 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RNA
AVIDITY BIOSCIE...
|
Healthcare | 0.00% | 4.96% |
Sold All 😨
(Was: #3) |
0.3 | -844,633 | -100.0% |
CLOSED
|
— | $— | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AKRO
AKERO THERAPEUT...
|
Healthcare | 0.00% | 4.12% |
Sold All 😨
(Was: #6) |
0.3 | -643,636 | -100.0% |
CLOSED
|
— | $— | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
N/A
PUT
UNITED THERAPEU...
|
—
|
PUT Option | 0.00% | 3.39% |
Sold All 😨
(Was: #11) |
0.3 | -59,900 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
CDTX
CIDARA THERAPEU...
|
Healthcare | 0.00% | 2.85% |
Sold All 😨
(Was: #13) |
0.3 | -220,902 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 0.00% | 1.56% |
Sold All 😨
(Was: #20) |
0.3 | -211,000 | -100.0% |
CLOSED
|
— | $— | 2021 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VSTM
VERASTEM INC
|
Healthcare | 0.00% | 1.24% |
Sold All 😨
(Was: #26) |
0.3 | -1,042,757 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SRRK
SCHOLAR ROCK HL...
|
Healthcare | 0.00% | 1.17% |
Sold All 😨
(Was: #30) |
0.3 | -233,920 | -100.0% |
CLOSED
|
— | $— | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ALKS
ALKERMES PLC
|
Healthcare | 0.00% | 0.73% |
Sold All 😨
(Was: #35) |
0.3 | -180,513 | -100.0% |
CLOSED
|
— | $— | 2023 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BBOT
BRIDGEBIO ONCOL...
|
Healthcare | 0.00% | 0.71% |
Sold All 😨
(Was: #37) |
0.3 | -457,414 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
N/A
CALL
COGENT BIOSCIEN...
|
—
|
CALL Option | 0.00% | 0.70% |
Sold All 😨
(Was: #40) |
0.3 | -360,000 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
PHVS
PHARVARIS N V
|
Healthcare | 0.00% | 0.62% |
Sold All 😨
(Was: #43) |
0.3 | -183,903 | -100.0% |
CLOSED
|
— | $— | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BCAX
BICARA THERAPEU...
|
Healthcare | 0.00% | 0.53% |
Sold All 😨
(Was: #49) |
0.3 | -250,606 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KNSA
KINIKSA PHARMAC...
|
Healthcare | 0.00% | 0.47% |
Sold All 😨
(Was: #51) |
0.3 | -88,910 | -100.0% |
CLOSED
|
— | $— | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EYPT
EYEPOINT PHARMA...
|
Healthcare | 0.00% | 0.44% |
Sold All 😨
(Was: #53) |
0.3 | -230,837 | -100.0% |
CLOSED
|
— | $— | 2021 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ZURA
ZURA BIO LTD
|
Healthcare | 0.00% | 0.42% |
Sold All 😨
(Was: #55) |
0.3 | -720,452 | -100.0% |
CLOSED
|
— | $— | 2023 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DCTH
DELCATH SYS INC
|
Healthcare | 0.00% | 0.29% |
Sold All 😨
(Was: #60) |
0.3 | -203,386 | -100.0% |
CLOSED
|
— | $— | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CRNX
CRINETICS PHARM...
|
Healthcare | 0.00% | 0.28% |
Sold All 😨
(Was: #61) |
0.3 | -50,000 | -100.0% |
CLOSED
|
— | $— | 2021 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CAMP
CAMP4 THERAPEUT...
|
Healthcare | 0.00% | 0.26% |
Sold All 😨
(Was: #62) |
0.3 | -653,594 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DYN
DYNE THERAPEUTI...
|
Healthcare | 0.00% | 0.17% |
Sold All 😨
(Was: #64) |
0.3 | -100,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
LBRX
LB PHARMACEUTIC...
|
Healthcare | 0.00% | 0.15% |
Sold All 😨
(Was: #65) |
0.3 | -70,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
N/A
PUT
CAPRICOR THERAP...
|
—
|
PUT Option | 0.00% | 0.14% |
Sold All 😨
(Was: #66) |
0.3 | -144,700 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
MRSN
MERSANA THERAPE...
|
Healthcare | 0.00% | 0.14% |
Sold All 😨
(Was: #67) |
0.3 | -133,636 | -100.0% |
CLOSED
|
— | $— | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
N/A
PUT
ATYR PHARMA INC
|
—
|
PUT Option | 0.00% | 0.12% |
Sold All 😨
(Was: #69) |
0.3 | -1,250,000 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
IMVT
IMMUNOVANT INC
|
Healthcare | 0.00% | 0.11% |
Sold All 😨
(Was: #70) |
0.3 | -50,000 | -100.0% |
CLOSED
|
— | $— | 2020 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
N/A
PUT
ARCTURUS THERAP...
|
—
|
PUT Option | 0.00% | 0.10% |
Sold All 😨
(Was: #71) |
0.3 | -42,000 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
N/A
CALL
SYNDAX PHARMACE...
|
—
|
CALL Option | 0.00% | 0.10% |
Sold All 😨
(Was: #72) |
0.3 | -50,000 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
N/A
PUT
ULTRAGENYX PHAR...
|
—
|
PUT Option | 0.00% | 0.10% |
Sold All 😨
(Was: #73) |
0.3 | -25,000 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
N/A
CALL
MOONLAKE IMMUNO...
|
—
|
CALL Option | 0.00% | 0.06% |
Sold All 😨
(Was: #74) |
0.3 | -65,000 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
MODD
MODULAR MED INC
|
Healthcare | 0.00% | 0.06% |
Sold All 😨
(Was: #75) |
0.3 | -639,531 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BDSX
BIODESIX INC
|
Healthcare | 0.00% | 0.05% |
Sold All 😨
(Was: #76) |
0.3 | -49,607 | -100.0% |
CLOSED
|
— | $— | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MBX
MBX BIOSCIENCES...
|
Healthcare | 0.00% | 0.04% |
Sold All 😨
(Was: #77) |
0.3 | -15,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ELVN
ENLIVEN THERAPE...
|
Healthcare | 0.00% | 0.03% |
Sold All 😨
(Was: #78) |
0.3 | -10,675 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MLTX
MOONLAKE IMMUNO...
|
Healthcare | 0.00% | 0.03% |
Sold All 😨
(Was: #79) |
0.3 | -30,000 | -100.0% |
CLOSED
|
— | $— | 2023 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ARCT
ARCTURUS THERAP...
|
Healthcare | 0.00% | 0.01% |
Sold All 😨
(Was: #80) |
0.3 | -3,445 | -100.0% |
CLOSED
|
— | $— | 2021 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NKTR
NEKTAR THERAPEU...
|
Healthcare | 0.00% | 0.00% |
Sold All 😨
(Was: #81) |
0.3 | -365 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-25 of 103 holdings